Reuters logo
BRIEF-Opiant Pharmaceuticals Inc provides an update on Narcan nasal spray
September 15, 2017 / 11:27 AM / 2 months ago

BRIEF-Opiant Pharmaceuticals Inc provides an update on Narcan nasal spray

Sept 15 (Reuters) - Opiant Pharmaceuticals Inc

* Opiant Pharmaceuticals Inc provides an update on Narcan nasal spray

* Opiant Pharmaceuticals Inc - ‍Adapt has maintained price of Narcan nasal spray, including a discounted public interest price of $75 per two-dose pack​

* Opiant Pharmaceuticals Inc says ‍in over 40 states, Narcan nasal spray can now be purchased from pharmacies without a prescription​

* Opiant Pharmaceuticals - ‍Narcan surpasses $25 million of net sales for H1 calendar 2017, triggering SWK Funding Llc’s obligation to pay co additional $3.75 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below